Incyte Corporation (INCY) Insider Trading

Over the last 3 months, INCY insiders made 0 open-market buys and 4 sales, a net sale of -$5.2M (SEC Form 4). Over the last 6 months, 683 institutions increased and 536 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
4
Net (3m)
-$5.2M
Insider trades by month Buys Sells
Dec
Jan
Feb
Mar
Apr
May
Context3-month price -0.9%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
May 28, 2026BIENAIME JEAN JACQUESdirectorOption15,000$84.53
May 28, 2026Tray Thomasofficer: Principal Accounting OfficerSell2,051$97.35
May 28, 2026BIENAIME JEAN JACQUESdirectorTax13,059$97.10
May 21, 2026Clancy Paul JdirectorSell15,000$94.93
May 21, 2026Clancy Paul JdirectorOption15,000$84.53
May 20, 2026Stein Steven Hofficer: CMO & Head of Late-Stage Dev.Grant44,124—
May 20, 2026CAGNONI PABLO Jofficer: President, Global Head of R&DGrant31,517—
May 11, 2026BAKER BROS. ADVISORS LPdirector, 10 percent owner: Option15,000$84.53
May 6, 2026Upadhyay Suketuofficer: EVP & Chief Financial OfficerGrant38,429$97.14
May 6, 2026Upadhyay Suketuofficer: EVP & Chief Financial OfficerGrant26,343—
May 6, 2026Upadhyay Suketuofficer: EVP & Chief Financial OfficerGrant13,171—
Apr 21, 2026CAGNONI PABLO Jofficer: President, Global Head of R&DOption6,077$64.25
Apr 21, 2026CAGNONI PABLO Jofficer: President, Global Head of R&DSell18,667$96.50
Apr 21, 2026CAGNONI PABLO Jofficer: President, Global Head of R&DOption12,590$71.93
Apr 17, 2026CAGNONI PABLO Jofficer: President, Global Head of R&DGrant27,892—
Apr 17, 2026Stein Steven Hofficer: CMO & Head of Late-Stage Dev.Grant39,049—
Apr 17, 2026Meury Williamdirector, officer, other: Chief Executive OfficerOption125,000—
Apr 2, 2026HARRIGAN EDMUNDdirectorGrant269$94.12
Apr 2, 2026BAKER BROS. ADVISORS LPdirector, 10 percent owner: Grant421—
Apr 2, 2026Clancy Paul JdirectorGrant265$94.12
Mar 26, 2026Trotta Matteoofficer: EVP, GM, Dermatology USTax537$92.23
Mar 19, 2026CAGNONI PABLO Jofficer: President, R&DSell18,667$94.24
Mar 19, 2026CAGNONI PABLO Jofficer: President, R&DOption7,166$61.18
Mar 19, 2026CAGNONI PABLO Jofficer: President, R&DOption11,501$64.25
Feb 23, 2026CAGNONI PABLO Jofficer: President, R&DOption13,093$61.76
Feb 23, 2026CAGNONI PABLO Jofficer: President, R&DSell18,668$100.91
Feb 23, 2026CAGNONI PABLO Jofficer: President, R&DOption5,575$61.18
Feb 4, 2026Heeson Leeofficer: EVP, Head of Incyte IntlTax111$102.67
Feb 4, 2026Morrissey Michael Jamesofficer: EVP, Head of Tech. OperationsTax185$102.67
Jan 21, 2026Issa Mohamed Khairieofficer: EVP, Head of US OncologyGrant14,237$106.21

Source: INCY SEC Form 4 filings, latest May 28, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their INCY positions over the last 6 months (SEC Form 13F).

Increased
683
New positions
281
Reduced
536
Sold out
159
Largest moves
InstitutionActionSharesFiled
BAKER BROS. ADVISORS LPIncreased30.7MMay 15, 2026
BAKER BROS. ADVISORS LPIncreased30.7MFeb 17, 2026
VANGUARD GROUP INCReduced19.9MJan 29, 2026
BLACKROCK, INC.Increased19.0MMay 13, 2026
BLACKROCK, INC.Increased18.3MFeb 12, 2026
DODGE & COXReduced13.3MFeb 13, 2026
DODGE & COXReduced12.3MMay 14, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position10.9MMay 15, 2026
STATE STREET CORPReduced9.7MFeb 13, 2026
STATE STREET CORPReduced9.6MMay 15, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position7.8MMay 8, 2026
AQR CAPITAL MANAGEMENT LLCReduced6.7MFeb 17, 2026
AQR CAPITAL MANAGEMENT LLCReduced5.8MMay 15, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased5.0MFeb 9, 2026
GEODE CAPITAL MANAGEMENT, LLCReduced4.7MMay 15, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.

← Back to INCY overview (price, financials, earnings)